2011
DOI: 10.1038/npp.2011.85
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic Treatments for Cognitive Impairments

Abstract: Epigenetic mechanisms integrate signals from diverse intracellular transduction cascades and in turn regulate genetic readout. Accumulating evidence has revealed that these mechanisms are critical components of ongoing physiology and function in the adult nervous system, and are essential for many cognitive processes, including learning and memory. Moreover, a number of psychiatric disorders and syndromes that involve cognitive impairments are associated with altered epigenetic function. In this review, we wil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
54
0
7

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(63 citation statements)
references
References 156 publications
2
54
0
7
Order By: Relevance
“…Around 350 million people are affected by depression globally [1], and in Europe, depression affects 6.9% of the population [2]. WHO estimates that the burden of unipolar major depression will be the largest global cause for disability-adjusted life years in 2030 [3]. These figures highlight the challenges for healthcare systems, for professionals' clinical competence and first of all for people suffering from depressive symptoms [4].…”
Section: Introductionmentioning
confidence: 99%
“…Around 350 million people are affected by depression globally [1], and in Europe, depression affects 6.9% of the population [2]. WHO estimates that the burden of unipolar major depression will be the largest global cause for disability-adjusted life years in 2030 [3]. These figures highlight the challenges for healthcare systems, for professionals' clinical competence and first of all for people suffering from depressive symptoms [4].…”
Section: Introductionmentioning
confidence: 99%
“…Several drugs that are already well accepted for treatment of depression seem to engage epigenetic mechanisms, specifically HPTMs (Tsankova et al, 2006;Covington et al, 2009). To date, most psychiatric diseases or their corresponding animal models have been linked to epigenetic dysregulation (Graff and Mansuy, 2009;Ptak and Petronis, 2010;Day and Sweatt, 2012), and thus we expect that the next years will bring major advances in the contribution of epigenetic mechanisms to disease etiology. One key point will be to understand how epigenetic marks can be induced or manipulated at specific target sites with tissue or even cell-type specificity.…”
Section: Small Noncoding Rnas In Spermmentioning
confidence: 99%
“…Given that MBD1 interacts with H3K9 methyltransferases to establish silent chromatin (4), we evaluated the expression of specific enzymes known as modifiers of this site-euchromatic histone lysine N-methyltransferase 2, SUV39H1 (Drosophila), SUV39H2, and SETDB1-in the offspring (9). Of the four enzymes tested, only SETDB1 showed higher mRNA levels in the HFD-C group than in the C-C group (n = 7, 1.7-fold, P = 0.039) (Fig.…”
Section: Maternal Chronic Hfd Consumption Has a Long-term Effect On Nmentioning
confidence: 99%
“…New evidence shows an interaction between DNA and histone modifications mediated through methyl-binding domain (MBD) proteins (9). The MBD proteins, namely MeCP2 and MBD1-4, bind to methylated CpG sequences and recruit enzymatic machinery such as histone deacetylases (HDACs), suppressor of variegation 3-9 homolog 1 (SUV39H1), and other chromatin-remodeling complexes affecting transcription regulators.…”
mentioning
confidence: 99%